Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union
02:30am, Friday, 25'th Jul 2025
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency's (EMA) Committee fo
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
02:30am, Friday, 25'th Jul 2025
NEW YORK and MAINZ, GERMANY, July 25, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency's (EMA) Committee
I Am Buying 5 Blue-Chip Dividend Stocks That Have Been Crushed in 2025
03:12pm, Thursday, 24'th Jul 2025
Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable performance history.
5 Stocks Yielding 6% and More You Can Buy Now and Forget About Forever
09:41am, Thursday, 24'th Jul 2025
Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.
A study published on 29 June 2025 in international peer reviewed medical journal Expert Opinion on Drug Safety by Frey et al. has found that use of Pfizer's Depo-Provera (DMPA) for more than one year
Pfizer Completes Licensing Agreement with 3SBio
06:45am, Thursday, 24'th Jul 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) granting Pfizer exclusive rights for the develo
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (July 2025)
08:04pm, Wednesday, 23'rd Jul 2025
Shares of Pfizer (NYSE: PFE) surged 8.24% over the past month, reducing the stock’s year-to-date loss to 5.02%. Over the past year, PFE has fallen by 8.75%. Recently, the FDA announced it will o
The 5%+ Dividend Stocks I Love Today
07:34pm, Wednesday, 23'rd Jul 2025
Key Points Altria (NYSE: MO) and Bristol Myers Squibb (NYSE: BMY) are highlighted as strong dividend plays yielding over 7% and 5% respectively, offering income stability even amid moderate price unde
Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound
04:13pm, Wednesday, 23'rd Jul 2025
The excitement around artificial intelligence (AI) has led to most attention—and capital–being concentrated in one corner while forgetting others, creating a gap and massive opportunity for rotati
Here's What to Expect From Pfizer's Non-Oncology Drugs in Q2 Earnings
11:16am, Wednesday, 23'rd Jul 2025
PFE's non-oncology portfolio draws focus in Q2, with strength in Vyndaqel and Nurtec offsetting some vaccine softness.
Pfizer Nears Major Bottom: A Turning Point for Investors?
09:36am, Wednesday, 23'rd Jul 2025
Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% in its stock price.
Pfizer: Building The Next Oncology Empire
04:12am, Wednesday, 23'rd Jul 2025
$43Bn Seagen acquisition positions Pfizer to dominate the $140Bn antibody-drug conjugate market. Numerous potential blockbusters launching pre-2030 should strengthen its oncology portfolio to offse pa
8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth
04:11am, Wednesday, 23'rd Jul 2025
The exanthema market is projected to grow from USD 1.39 billion in 2024 to USD 2.51 billion by 2034 at a CAGR of 6.10%. This growth is driven by rising viral infections and diagnostic innovations acro
2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade
08:15am, Monday, 21'st Jul 2025
Pharmaceutical giants Pfizer (PFE -0.45%) and Novo Nordisk (NVO -1.50%) have lagged the market over the past year, although Pfizer's poor performance dates back much further. Though these companies ha
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
07:46am, Monday, 21'st Jul 2025
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
